IAAG
PPH icon

Innovative Asset Advisors Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Innovative Asset Advisors Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.6K Sell
554
-100
-15% -$10.3K 0.03% 258
2026
Q1 		$67.9K Buy
+654
New +$69.7K 0.04% 265

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Innovative Asset Advisors Group's PPH Position: Q2 2026 in Review

Innovative Asset Advisors Group reduced its VanEck Pharmaceutical ETF (PPH) stake by 15% in Q2 2026, selling an estimated $10.3K and leaving 554 shares worth $60.6K. The position accounts for 0.03% of the portfolio, ranked #258.

Innovative Asset Advisors Group first reported a position in PPH in Q1 2026 and has held it in 2 quarters since. The position peaked at $67.9K in Q1 2026. 139 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Innovative Asset Advisors Group held 554 shares of VanEck Pharmaceutical ETF worth $60.6K as of Q2 2026.
  • Innovative Asset Advisors Group sold 100 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $10.3K.
  • VanEck Pharmaceutical ETF made up 0.03% of Innovative Asset Advisors Group's portfolio in Q2 2026, its #258 holding.
  • Innovative Asset Advisors Group first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and has held it in 2 quarters since.
  • Innovative Asset Advisors Group's VanEck Pharmaceutical ETF position peaked at $67.9K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.